UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 883

Sortiert nach

Epidemiological Features of NAFLD From 1999 to 2018 in China

Hepatology (Baltimore, Md.), 2020-05, Vol.71 (5), p.1851-1864

2020

Link zum Volltext

Verfügbarkeit prüfen

Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis

Hepatology (Baltimore, Md.), 2019-10, Vol.70 (4), p.1119-1133

2019

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China

Hepatology (Baltimore, Md.), 2020-08, Vol.72 (2), p.389-398

2020

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases

Circulation research, 2020-02, Vol.126 (5), p.679-704

2020

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice

World journal of gastroenterology : WJG, 2019-03, Vol.25 (11), p.1307-1326

2019

Link zum Volltext

Verfügbarkeit prüfen

Self-Sealing Porous Silicon-Calcium Silicate Core-Shell Nanoparticles for Targeted siRNA Delivery to the Injured Brain

Advanced materials (Weinheim), 2016-09, Vol.28 (36), p.7962-7969

2016

Link zum Volltext

Verfügbarkeit prüfen

Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD

Hepatology (Baltimore, Md.), 2021-11, Vol.74 (5), p.2508-2525

2021

Link zum Volltext

Verfügbarkeit prüfen

Time to step‐up the fight against NAFLD

Hepatology (Baltimore, Md.), 2018-06, Vol.67 (6), p.2068-2071

2018

Link zum Volltext

Verfügbarkeit prüfen

Milk Fat Globule–Epidermal Growth Factor–Factor 8 Improves Hepatic Steatosis and Inflammation

Hepatology (Baltimore, Md.), 2021-02, Vol.73 (2), p.586-605

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Potential of G Protein‐Coupled Receptors Against Nonalcoholic Steatohepatitis

Hepatology (Baltimore, Md.), 2021-11, Vol.74 (5), p.2831-2838

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte TNF Receptor–Associated Factor 6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lysine 6–Linked Polyubiquitination of Apoptosis Signal‐Regulating Kinase 1

Hepatology (Baltimore, Md.), 2020-01, Vol.71 (1), p.93-111

2020

Link zum Volltext

Verfügbarkeit prüfen

Advances of asphalt pavement runoff models

Journal of physics. Conference series, 2023-03, Vol.2458 (1), p.12038

2023

Link zum Volltext

Verfügbarkeit prüfen

TNFAIP3 Interacting Protein 3 Is an Activator of Hippo‐YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury

Hepatology (Baltimore, Md.), 2021-10, Vol.74 (4), p.2133-2153

2021

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia

Circulation research, 2021-05, Vol.128 (11), p.1747-1765

2021

Link zum Volltext

Verfügbarkeit prüfen

Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis

Clinical science (1979), 2020-07, Vol.134 (13), p.1775

2020

Link zum Volltext

Verfügbarkeit prüfen

Integrated Omics Reveals Tollip as an Regulator and Therapeutic Target for Hepatic Ischemia‐Reperfusion Injury in Mice

Hepatology (Baltimore, Md.), 2019-11, Vol.70 (5), p.1750-1769

2019

Link zum Volltext

Verfügbarkeit prüfen

The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin‐Mediated Degradation of 3‐Hydroxy‐3‐Methylglutaryl CoA Reductase Degradation Protein 1

Hepatology (Baltimore, Md.), 2021-12, Vol.74 (6), p.3018-3036

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta–Activated Kinase 1–c‐Jun‐N‐Terminal Kinase/p38 Signaling

Hepatology (Baltimore, Md.), 2021-01, Vol.73 (1), p.104-125

2021

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis

Cell metabolism, 2020-05, Vol.31 (5), p.892-908.e11

2020

Link zum Volltext

Verfügbarkeit prüfen

F‐box/WD Repeat‐Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal‐Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice

Hepatology (Baltimore, Md.), 2019-12, Vol.70 (6), p.1942-1957

2019

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD

Hepatology (Baltimore, Md.), 2021-09, Vol.74 (3), p.1319-1338

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 883

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(733)
Mit Volltextzugriff
(794)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(549)
Life Sciences & Biomedicine
(323)
Humans
(179)
Physical Sciences
(170)
Technology
(145)
Animals
(134)
Chemistry
(108)
Mice
(83)
Male
(81)
Materials Science
(80)
Engineering
(72)
Materials Science, Multidisciplinary
(62)
Female
(58)
Pharmacology & Pharmacy
(53)
Physics
(51)
Chemistry, Medicinal
(43)
Chemistry, Multidisciplinary
(43)
Biochemistry & Molecular Biology
(40)
Cell Biology
(40)
Cardiovascular System & Cardiology
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Epidemiological Features of NAFLD From 1999 to 2018 in China

Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis

Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice

Self-Sealing Porous Silicon-Calcium Silicate Core-Shell Nanoparticles for Targeted siRNA Delivery to the Injured Brain

Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD

Time to step‐up the fight against NAFLD

Milk Fat Globule–Epidermal Growth Factor–Factor 8 Improves Hepatic Steatosis and Inflammation

Therapeutic Potential of G Protein‐Coupled Receptors Against Nonalcoholic Steatohepatitis

Hepatocyte TNF Receptor–Associated Factor 6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lysine 6–Linked Polyubiquitination of Apoptosis Signal‐Regulating Kinase 1

Advances of asphalt pavement runoff models

TNFAIP3 Interacting Protein 3 Is an Activator of Hippo‐YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury

Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia

Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis

Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes

Integrated Omics Reveals Tollip as an Regulator and Therapeutic Target for Hepatic Ischemia‐Reperfusion Injury in Mice

The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin‐Mediated Degradation of 3‐Hydroxy‐3‐Methylglutaryl CoA Reductase Degradation Protein 1

Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta–Activated Kinase 1–c‐Jun‐N‐Terminal Kinase/p38 Signaling

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis

F‐box/WD Repeat‐Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal‐Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice

The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19

Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD

Suchergebnisse filtern